Some Biological Properties of New Quinoline-4-carboxylic Acid and Quinoline-4-carboxamide Derivatives

Folia Microbiologica

Volumn 45, Issue 4, 2000, Pages 305-309

  Strigacova J ^a   Hudecova D ^a   Varecka L' ^a   Lasikova A ^a   Vegh D ^a  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; ANTIINFECTIVE AGENT; QUINOLINE 4 CARBOXYLIC ACID; QUINOLINE DERIVATIVE; QUINOLINE-4-CARBOXYLIC ACID;

ARTICLE; BACTERIUM; BOTRYTIS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FUNGUS; GOOSEFOOT; METABOLISM; MICROBIOLOGICAL EXAMINATION;

ANTHOCYANINS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; BOTRYTIS; CHENOPODIACEAE; FUNGI; MICROBIAL SENSITIVITY TESTS; QUINOLINES;

EID: 0034570227     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02817551     Document Type: Article

References (16)

1. DOBSON R.A., O'CONNOR J.R., POULIN S.A., KUNDSIN R.B., SMITH T.F., CAME P.E.: In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis and Ureaplasma urealyticum. Antimicrob.Agents Chemother. 18, 738-740 (1980).
2. HOLDER I.A., KNOLL C.A., WESSELMAN J.: Norfloxacin and silver-norfloxacon as topical antimicrobial agents: results of in vitro susceptibility testing against bacteria and Candida sp. isolated from burn patients. J.Burn.Care Rehabil. 7, 479-483 (1986).
3. HOLM F.: Aminopropylacridans. Brit.Pat. 933 875; Chem.Abstr. 60, 510a (1963).
4. HUDECOVÁ D., JANTOVÁ S., MELNÍK M., UHER M.: New azidometalkojates and their biological activity. Folia Microbiol. 41, 473-476 (1996).
5. JANTOVÁ S., HUDECOVÁ D., STANKOVSKÝ Š., ŠPIRKOVÁ K., RUŽEKOVÁ L'.: Antibacterial effect of substituted 4-quinazolyl-hydrazines and their arylhydrazones determined by a modified microdilution method. Folia Microbiol. 40, 611-614 (1995).
6. KOSAKAI N., KUMAMOTO Y., SAKAI S., HIROSE T., OKAYAMA S., SHIGETA S., SHIRAIWA Y., YOSHIDA H., MIURA Y., OGATA M.: Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). III. Secular changes in susceptibility. Japan J.Antibiot. 40, 2026-2142 (1987).
7. LACKEY N., STERNBACH D.D.: Synthesis of substituted quinoline-4-carboxylic acids. Synthesis 993-997 (1993).
8. LÁSIKOVÁ A., VÉGH D.: Synthetic use of the Pfitzinger reaction in preparation of 2(3)-(di)substituted derivatives of quinoline-4-carboxylic acids. Chem.Papers 51, 408-411 (1997).
9. LIGTVOET E.E., WICKLERHOFF-MINOGGIO T.: In-vitro activity of pefloxacin compared with six other quinolones. J.Antimicrob. Chemother. 16, 485-490 (1985).
10. MAJTÁNOVÁ L'., MAJTÁN V.: Postantibiotic effects of imipenem and enoxacin against S. typhimurium and S. enteritidis and the influence on their surface hydrophobicity. Folia Microbiol. 43, 104-108 (1998).
11. MARBLE D.A., BOSSO J.A.: Norfloxacin: a quinoline antibiotic. Drug Intell.Clin.Pharm. 20, 261-266 (1986).
12. NEMEC P., BETINA V.: Permeability alterations in beet root Beta vulgaris var. rubra caused by amphotericin B. J.Antibiot. 21, 626-627 (1968).
13. POLÓNYI J., EBRINGER L., DOBIAS J., KRAJČOVIČ J.: Giant mitochondria in chloroplast-deprived Euglena gracilis late after N-succinimidylofloxacin treatment. Folia Microbiol. 43, 661-666 (1998).
14. SEKAR M., PRASAD K.J.: Synthesis of some novel 2-oxo-pyrano(2,3-b)- and 2-oxo-pyrido(2,3-b)quinoline derivatives as potential antimalarial, diuretic, clastogenic and antimicrobial agents. J.Chem.Technol.Biolechnol. 72, 50-54 (1998).
15. WISE R., ANDREWS J.M., DANKS G.: In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents. J.Antimicrob.Chemother. 13, 237-244 (1984).
16. WOODWARD R.B., EASTMAN R.H.: Dimerization of 6-methoxy-3,4-dihydronaphthalene. J.Am.Chem.Soc. 66, 849 (1944).